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OBJECTIVE: To investigate the effect of a 2-year multido-
main lifestyle intervention on daily functioning of older
people.
DESIGN: A 2-year randomized controlled trial (ClinicalTrials.
gov, NCT01041989).
SETTING: Finnish Geriatric Intervention Study to Prevent
Cognitive Impairment and Disability.
PARTICIPANTS: A total of 1260 older adults, with a mean
age of 69 years at the baseline, who were at risk of cogni-
tive decline.
INTERVENTION: A multidomain intervention, including
simultaneous physical activity intervention, nutritional
counseling, vascular risk monitoring and management, and
cognitive training and social activity.
MEASUREMENTS: The ability to perform daily activities
(activities of daily living [ADLs] and instrumental ADLs) and
physical performance (Short Physical Performance Battery).
RESULTS: The mean baseline ADL score was 18.1 (SD = 2.6)
points; the scale ranges from 17 (no difﬁculties) to 85 (total
ADL dependence). During the 2-year intervention, the ADL dis-
ability score slightly increased in the control group, while in the
intervention group, it remained relatively stable. Based on the
latent growth curve model, the difference in the change between
the intervention and control groups was −0.95 (95% conﬁ-
dence interval [CI] = −1.61 to −0.28) after 1 year and −1.20
(95% CI = −2.02 to −0.38) after 2 years. In terms of physical
performance, the intervention group had a slightly higher prob-
ability of improvement (from score 3 to score 4; P = .041) and a
lower probability of decline (from score 3 to scores 0-2;
P = .043) for chair rise compared to the control group.
CONCLUSION: A 2-year lifestyle intervention was able to
maintain the daily functioning of the at-risk older popula-
tion. The clinical signiﬁcance of these results in this fairly
well-functioning population remains uncertain, but the
study results hold promise that healthy eating, exercise, and
cognitive and social activity may have favorable effects on
functional independence in older people. J Am Geriatr Soc
00:1–7, 2019.
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Adequate ability to perform daily tasks and physicalperformance are prerequisites for independent living. Dis-
ability refers to difﬁculties performing or the inability to per-
form basic activities of daily living (BADLs), such as bathing,
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dressing, and transferring into a bed,1 or more demanding in-
strumental activities of daily living (IADLs), such as coping
with housework, handling ﬁnances, or using a telephone.2
The disablement model by Verbrugge and Jette (1994) demon-
strates how functional limitations usually precede disability in
BADLs and IADLs.3 Functional decline and disability increase
the risk of several adverse health events, including injuries,4
hospital care, and premature death.5
Lifestyle-related risk factors for disability have been rela-
tively widely reported. Longitudinal studies have reported that
physically inactive persons reach the disability threshold level
earlier.6 A healthy diet and avoiding obesity are also associated
with lower risk of functional decline in older people,7 and sev-
eral chronic conditions, including high blood pressure and car-
diovascular diseases, may accelerate the decline.8 However,
only a few large randomized controlled trials (RCTs) have
investigated whether simultaneous changes in diet, increasing
physical exercise, or modifying cardiovascular risks slow
down the progression or prevent BADL/IADL disabilities. A
few recent intervention studies with different designs have not
produced uniform results.9,10
This study reports ﬁndings from the FinnishGeriatric Inter-
vention Study to Prevent Cognitive Impairment and Disability
(FINGER), which is the ﬁrst large RCT targeting persons at risk
of cognitive decline with a multidomain intervention, including
simultaneous physical activity, nutritional counseling, vascular
risk monitoring and management, and cognitive training and
social activity.11,12 The FINGER study has demonstrated
signiﬁcant intervention effects on the primary outcome (overall
cognition) and main cognitive secondary outcomes (executive
functioning and processing speed).Most secondary outcomes12
of the FINGER study have already been reported.13–15 For
health resources, biomarkers and mortality analyses are ongo-
ing. In the current study, we evaluated whether a multidomain
lifestyle intervention reduces a decline in physical performance
measured by testing standing balance, a timed sit to stand, and
4 m comfortable walking time.12 We also conducted explor-
atory analyses investigating the intervention effects on disability
measured with a self-reported assessment of the ability to per-
form daily living activities.
METHODS
Participants
FINGER (ClinicalTrials.gov identiﬁer: NCT01041989)11–13
includes altogether 1260 independently living older persons
from six cities in Finland. The full FINGER study protocol,
recruitment of the participants, baseline characteristics, and
outcomes have been reported in detail previously.11,12 The
inclusion criteria were that the participants were at an age of
60 to 77 years at the start of the study, had a Cardiovascular
Risk Factors, Aging and Dementia Risk Score16 of 6 points or
higher, and had a cognitive performance at the mean level
or slightly lower than expected for their age, according to
Finnish population norms tested with the Consortium to
Establish a Registry for Alzheimer’s Disease neuropsychologi-
cal battery.17 Persons with previously diagnosed or suspected
dementia, disorders affecting safe engagement in the interven-
tion (eg, malignant disease, major depression, symptomatic
cardiovascular disease, revascularization within 1 year previ-
ously), severe loss of vision, hearing, or communicative ability,
and disorders preventing cooperation, as judged by the study
physician, were excluded.
FINGER Intervention
Participants were randomly assigned into groups receiving an
intensive multidomain intervention or regular health advice
(control group) at a 1:1 ratio. Computer-generated allocation
was carried out in blocks of four (two individuals randomly
allocated to each group) at each site after the baseline by the
study nurse. The group allocation was not actively explained
to the participants. The intervention components have been
described in detail previously.11,12 Brieﬂy, the multidomain
intervention included simultaneous physical activity interven-
tion, nutritional counseling, vascular risk monitoring and
management, and cognitive training and social activity. The
nutritional component was based on the Finnish Nutrition
Recommendations18 and was conducted by study nutritionists
(three individual sessions and seven to nine group sessions).
The physical activity component was based on international
guidelines19 and a modiﬁed version of the Dose Responses to
Exercise Training study protocol.20 Training was guided by
physiotherapists at a gym and consisted of individually tai-
lored programs for progressive muscle strength training (one
to three times per week) and aerobic exercise (two to ﬁve times
per week). Exercises improving postural balance were also
included. Cognitive training included 10 group sessions led by
a psychologist. Individual sessions consisted of independent
computer-based training at home or at the study site. Two
6-month periods included 72 training sessions each (three
times per week, 10-15 minutes per session). The training
program was a web-based in-house developed computer pro-
gram, which included several cognitive tasks adapted from
previous RCTs.21 Social activities were stimulated through the
numerous group meetings. The management of metabolic and
vascular risk factors was based on national evidence-based
guidelines.22–24 Blood pressure, weight, body mass index
(BMI), and hip and waist circumference were regularly exam-
ined, and the participants received advice on leading a healthy
lifestyle. Adherence was the highest for cardiovascular moni-
toring and individual nutritional counseling, intermediate for
cognitive training and nutrition group visits, and lower for
independent gym training and computerized computer train-
ing (more detailed adherence data are presented in Table S1).
The FINGER study was approved by the coordinating
ethics committee of the Hospital District of Helsinki and
Uusimaa. The participants gave their informed written con-
sent prior to the study.
Outcome Measures
Activities of Daily Living Disability
BADLs and IADLs were assessed using questionnaires.1,2,25
Hereafter in the text, we use the term ADL to refer to the ques-
tionnaire covering both BADL and IADL components. The
questionnaire included 17 items. The ability to perform the fol-
lowing daily activities was assessed: toileting, eating, bathing,
moving to and out of bed, dressing, moving indoors, walking
up and down stairs, cutting toe nails, taking and handlingmed-
ications, using a telephone, cooking, light housework, handling
ﬁnances, doing laundry, using public transportation, shopping,
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and heavy housework. The response options were (1) able to
independently perform the activity without any difﬁculties;
(2) able to independently perform the activity, but with minor
difﬁculties; (3) able to independently perform the activity, but
with major difﬁculties; (4) able to perform the activity only
when assisted; and (5) not able to perform the activity even
when assisted. A sum score based on the ADL questions (range
= 17-85), at the baseline, 12-month follow-up, and 24-month
follow-up, was calculated. Higher score indicated poorer daily
functioning, and a score of 17 indicated no problems in
any task.
Physical Performance
The Short Physical Performance Battery (SPPB)26 was admin-
istered to all participants before and after the intervention
period. The SPPB consists of three subtests: a hierarchical test
of balance, a 4-m walk at a normal pace, and standing up
from a chair ﬁve times consecutively. In the balance test, the
participants were asked to remain standing with their feet as
close together as possible, then in a semitandem position (ie,
with the heel of one foot alongside the big toe of the other
foot), and ﬁnally in a tandem position (ie, with the heel of
one foot directly in front of the other foot and touching it).
Each position had to be held for 10 seconds. For gait speed,
the time required to walk 4 m at a normal pace was mea-
sured. This test was repeated twice, and the better time of
the two was used in the analyses. For the chair rise test, par-
ticipants were asked to stand up and sit down in a chair ﬁve
times as quickly as they could with their arms crossed over
the chest, and the time required was measured. Each test was
scored from 0 (worst performance) to 4 (best performance).
We have previously reported analyses with the continuous
SPPB sum score as an outcome. The intervention and control
groups did not differ signiﬁcantly, but the estimate (95%
conﬁdence interval [CI]) was 0.03 (−0.04 to 0.10) in favor
of intervention13 The present analyses were done to investi-
gate the intervention effects on the chair rise, balance, and
walking ability, because the intervention may have different
effects on these tasks, which vary in difﬁculty.
Statistical Analyses
We applied a latent growth curve modeling approach for
the ADL using all three time points (baseline, 12 months,
and 24 months) to analyze the change during 24 months.
To account for a nonnormal distribution of the ADL, a cen-
sored normal model was assumed with a minimum ADL
score (17) as censoring point (ie, ﬂoor effect). Change was
assumed to be nonlinear by estimating the shape parameter
(ie, factor loading for a 12-month score) of the growth fac-
tor as free as opposed to a linear change model where the
shape parameter is ﬁxed. Mplus version 5.1 was used with
full information maximum likelihood (FIML) estimation.
FIML uses all available data by assuming that missing data
are random. Because of the censored normal model, the
integration algorithm was applied.
For ordinal scale SPPB scores, an ordered logistic regres-
sion model was applied. For analyses, participants with scores
of 0 to 2 in each domain were combined due to the limited
number of persons in these categories. A 24-month score was
the model outcome, while the baseline score, group, and
baseline score–group interaction were the covariates. Based on
an ordered logistic regression model, conditional transitions
by model covariate categories were estimated with 95% CIs
and differences between groups were tested. An omnibus
P value for all transitions was calculated by testing the joint
hypotheses (Stata’s test command, applying accumulate
option).
Additional analyses using logistic regression, including
only the persons without any difﬁculties in the ADLs (total
score = 17, n = 774) at the baseline and persons without
any difﬁculties in the SPPB (total score = 12, n = 460) at
the baseline, were conducted to investigate the risk for ADL
and SPPB incident difﬁculties in the intervention and con-
trol groups.
RESULTS
Population Characteristics
At the baseline, the participants’ ages ranged from 60 to
77 years (mean = 69 years). The mean Mini-Mental State
Examination score at the baseline was 26.7 points, the mean
BMI was 28.2 kg/m2, and the mean education level was
10 years. A total of 71% were physically active at least twice
a week. The baseline characteristics for the participants in
the intervention and control groups are presented in Table 1.
The ﬂowchart shows the number of participants assessed for
eligibility and the ﬂow of participants (Figure 1).
The ADL sum score in FINGER participants ranged
from 17 to 46 at the baseline, from 17 to 51 at the
12-month follow-up, and from 17 to 59 at the 24-month
follow-up. In comparison, the full range of the ADL scale
was from 17 (no difﬁculties) to 85 (total ADL dependence).
The mean ADL total score at the baseline was 18.1 (SD =
2.6) points, and the mean SPPB score was 10.8 (12 points
indicating no difﬁculties). Table 2 shows the mean ADL
and SPPB scores at the baseline and the mean change over
time. The number of persons with difﬁculties in ADL and
functional performance are presented in Table S2.
Results from the latent growth curve modeling showed
that the ADL disability score slightly increased in the control
group (the 12-month estimated mean change was 0.88 [95%
CI = 0.34-1.42]; and for 24 months, it was 1.10 [95% CI =
0.53-1.67]), while in the intervention group, it remained sta-
ble (the 12-month estimated mean change was −0.12 [95%
CI = −0.61 to 0.38]; and for 24 months, it was −0.15 [95%
CI = −0.77 to 0.48]). The difference in the change between
the intervention and control groups was −0.95 (95% CI =
−1.61 to −0.28) after 1 year and −1.20 (95% CI = −2.02 to
−0.38) after 2 years, indicating increased disability in the
control group compared to the intervention group (Figure 2).
The effect size (Cohen’s d) and the 95% CI for ADL was
−0.31 (95% CI = −0.53 to −0.09) after 1 year and −0.39
(95% CI = −0.66 to −0.12) after 2 years.
The FINGER participants displayed good physical per-
formance, and it remained relatively stable over 2 years.
Distributions of the SPPB scores at baseline and at the
2-year follow-up are shown in Table S3. A total of 227 par-
ticipants improved (30%) and 308 declined (22%) in their
total SPPB scores over the 2 years, with a mean improve-
ment of 1.5 (SD = 0.9) points and a mean decline of −1.2
(SD = 0.5) points. Signiﬁcant differences in the transitions
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between the groups were observed only for the chair rise
test, where the intervention group had a slightly higher
probability of improving and a lower probability of decline
compared to the control group. All the transitions in the
chair rise, balance, and walking test, according to the
baseline score and group, and differences between the inter-
vention and control group (percentage with 95% CIs) are
shown in Tables S4 to S6.
The risk of incident ADL disability among those with-
out any baseline difﬁculties during the 2-year intervention
period was signiﬁcantly lower in the intervention group
(odds ratio [OR] = 0.57; 95% CI = 0.39-0.84). Intervention
was not associated with incident limitations in physical per-
formance (OR = 1.29; 95% CI = 0.84-2.00).
DISCUSSION
This study showed that a 2-year multidomain intervention
could maintain daily functioning of older people who are at
risk of cognitive decline. The ADL disability score slightly
increased in the control group during the intervention,
while in the intervention group, it remained stable. Inter-
vention also had small favorable effects on chair rise. The
clinical signiﬁcance of these ﬁndings observed in a fairly
well-functioning population remains uncertain. Although
statistically signiﬁcant, the observed changes in ADL score
were small during the short within-study follow-up period
of 2 years. The trial was powered to demonstrate the effec-
tiveness of the intervention, and the true potential of the
intervention will become clear after a longer follow-up time.
Still, this beneﬁcial effect on ADLs after 2 years in an older
population who are at risk for cognitive decline may be rel-
evant for public health.
The current study is among the ﬁrst trials showing the
effects of a multifactorial lifestyle intervention on the daily
functioning and physical performance of community-dwelling
older people who are at risk of cognitive decline. Maintaining
or improving physical functioning and detecting the ﬁrst signs
Table 1. FINGER Study Population in the Intervention
and Control Groups
Characteristics
Participants
With
Information
Available
Intervention
Groupa
Control
Groupa
Sex (women) 1260 286 (45) 303 (48)
Age, y 1260 69.7 (4.6) 69.4 (4.7)
Education, y 1258 10.0 (3.5) 10.0 (3.4)
Physical activity at least
twice a week
1247 436 (70) 447 (72)
Body mass index, kg/m2 1249 28.3 (4.5) 28.1 (4.9)
Diabetes 1253 86 (14) 79 (13)
MMSE scoreb 1257 26.7 (2.1) 26.8 (2.0)
ADL score (baseline)c 1210 18.2 (2.9) 18.1 (2.4)
SPPB score (baseline)d 1210 10.8 (1.4) 10.8 (1.4)
aData are given as number (percentage) or mean (SD).
bThe MMSE score range is from 0 to 30 (a higher score indicates better
cognition).
cThe ADL score range is from 17 to 85 (a higher score indicates more
disability).
dThe SPPB score range is from 0 to 12 (a higher score indicates better physi-
cal performance).
Abbreviations: ADL, activity of daily living; FINGER, Finnish Geriatric
Intervention Study to Prevent Cognitive Impairment and Disability; MMSE,
Mini-Mental State Examination; SPPB, Short Physical Performance Battery.
2654 Individuals assessed for eligibility
for the FINGER trial
1260 Participants randomly assigned
1394 Not enrolled
- 1108 Did not meet inclusion criteria (1097 
high cognitive
performance, 7 low cognitive performance, 
4 CERAD
not completed)
- 142 Had exclusion criteria (116 medical
disorder, 26 other
ongoing intervention)
- 144 For other reasons (not willing or able 
to participate, or dropped out before
randomization) 
631 to Intervention
Baseline data available:
ADL (n = 603)
SPPB (n = 604)
SPPB domains (n = 604)
12 mo:
ADL (n = 539)
SPPB not available
12 mo:
ADL (n = 557)
SPPB (not available)
629 to Control
Baseline data available:
ADL (n = 607)
SPPB (n = 606)
SPPB domains (n = 606-607)
24 mo:
ADL (n = 536)
SPPB (n = 518)
SPPB domains (n = 521-604)
24 mo:
ADL (n = 534)
SPPB (n = 532)
SPPB domains (n = 534-535)
Included in analysis:
ADL (n = 555)
SPPB (n = 513)
SPPB domains (n = 513-516)
Included in analysis:
ADL (n = 567)
SPPB (n = 523)
SPPB domains (n = 525-527)
5 Died
82 Discontinued
intervention
26 For health-
related reasons
12 Due to lack of 
time or motivation
14 Had difficulties
arranging
participation
14 For other
reasons
16 For unknown
reason
8 Died
58 Discontinued
intervention
29 For health-
related reasons
10 Due to lack of 
time or motivation
4 Had difficulties
arranging
participation
7 For other
reasons
8 For unknown
reason
Figure 1. Study ﬂowchart. ADL, activity of daily living; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; FIN-
GER, Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability; SPPB, Short Physical Performance
Battery.
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of functional decline at the ages of 65 to 80 years may have far-
reaching implications for improving functional independence
after the age of 80 years.27 In most countries, the oldest old are
now the fastest-growing part of the overall population, and it
is essential to ﬁnd ways to promote their healthy and indepen-
dent living. The multidomain intervention was associated with
lower odds of incident ADL disabilities. This may have clinical
signiﬁcance, since it has been previously shown that moving
from being robust to physically frail within a few-years’ time
signiﬁcantly increases the mortality risk.28 Our ﬁndings are
supported by the cohort study showing that better walking
ability and a better-quality diet were signiﬁcantly associated
with a compression of the disabled period.29
In our study of a population with a mean age of
69 years, 36% had at least some difﬁculties in daily activi-
ties at the baseline and 62% had at least some difﬁculties in
physical performance. However, the mean ADL total score
at the baseline was 18 points (17 points indicating no difﬁ-
culties in ADLs) and the mean SPPB score was 11 points
(12 points indicating no difﬁculties), which indicated that
the participants in the FINGER study were healthy and
functionally independent. Previous studies have shown that
the ADL/IADL disability ranges between 2% and 20%30–32
among older people aged 60 to 80 years, depending on the
age group and ADL disability deﬁnition used. Thus, our
sample can be considered representative of the population
at this age. Changes in outcomes during the 2-year interven-
tion in this well-functioning population were relatively
small. In single-domain intervention studies with similar
outcomes, larger changes have been observed; however, the
study populations have been older and with more func-
tional limitations at the baseline.33,34
A few study limitations must be considered. Due to a
relatively well-functioning study population, there was only
a little room for improvement in physical functioning during
the 2-year period and the outcome measures used may have
had a ceiling effect. The currently ongoing FINGER 7-year
follow-up phase will provide more information on the
longer-term effects of the intervention as the individuals get
older and most likely develop more impairments. The aim of
the FINGER intervention was to target an at-risk population
and to start early before cognitive or functional decline has
started. Therefore, it is not easy to see the intervention effects
after 2 years. However, by starting early, we will most likely
achieve better long-term effects. Also due to the small num-
ber of participants in some of the categories in the functional
performance tests, the lack of statistical power in some of the
analyses may limit the ﬁndings. Although the subgroup ana-
lyses showed that the intervention prevented incident ADL
limitations, these results should be interpreted with caution
because the changes were small, and the two groups were
slightly different at the baseline and adjusting for the baseline
level may not correct this completely. The main outcome of
the FINGER study was cognition, and the multidomain
intervention was not speciﬁcally planned for improving daily
functioning.
Figure 2. Change in the activity of daily living (ADL) score
during the 2-year intervention period. The ﬁgure shows the
estimated mean change in the ADL score (range = 17-85) from
the baseline up to 12 and 24 months (a higher score suggests
greater disability). The error bars are conﬁdence intervals. A
latent growth curve modeling approach using all three time
points (baseline, 12 months, and 24 months) was used. The
P value is from the Wald Test of Parameter Constraints.
Table 2. The Mean ADL and SPPB Scores at Baseline and Mean Change Over Time
Variable Baseline 12 mo 24 mo
ADL Factors
ADL disability score at baseline and change, mean (SD)a
All (n = 1210) 18.1 (2.6) 0.4 (2.0) 0.5 (2.1)
Intervention group (n = 603) 18.2 (2.9) 0.3 (2.2) 0.5 (2.2)
Control group (n = 607) 18.1 (2.4) 0.5 (1.8) 0.5 (2.0)
Participants who changed from no disability to at least some disability during 24 mo, %b
Intervention group 17 16
Control group 23 25
Physical Performance Factor
SPPB score at baseline and change, mean (SD)c
All (n = 1210) 10.8 (1.4) NA −0.2 (1.1)
Intervention group (n = 604) 10.8 (1.4) NA −0.2 (1.1)
Control group (n = 606) 10.8 (1.4) NA −0.2 (1.1)
aThe ADL score range is from 17 to 85 (a higher score indicates more disability).
bA score of 18 or more refers to at least some difﬁculties.
cThe SPPB score range is from 0 to 12 (a higher score indicates better performance).
Abbreviations: ADL, activity of daily living; NA, Not available; SPPB, Short Physical Performance Battery.
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Due to the multidomain approach, it is not possible to
exactly state the individual effects of different intervention
components on the observed effects. For similar outcomes, pre-
vious studies with physical activity interventions have pro-
vided beneﬁcial effects on physical functioning35,36 and,
therefore, it is likely that intensive physical activity training is
one of the key components of the FINGER program. In future
studies, the FINGER-type multimodal intervention model
needs to be investigated further, particularly with regard to the
contribution of each component to the overall effect.
The strengths of this study include the controlled ran-
domized study design with a large sample size, longer dura-
tion than in most trials, detailed outcome assessments, and
high-quality data collection. The multidomain lifestyle inter-
vention was found to be feasible and safe, with no serious
adverse events.13 Also, the dropout rate was low (12%). We
used validated performance-based outcome measures of
physical performance and the widely used scale of ADL func-
tions. This study provides a reference frame for changes in
daily functioning for older people who are at risk of demen-
tia but have not yet developed signiﬁcant impairments.
Independent daily functioning and physical performance
in older people are inﬂuenced by a wide range of health- and
lifestyle-related factors. A multidomain intervention simulta-
neously targeting multiple risk factors may prevent ADL dis-
abilities in the older at-risk population. The FINGER study
has shown that modifying older at-risk people’s lifestyles has
beneﬁcial effects on cognition13 quality of life,14 and, as
shown in the present study, daily functioning. This study,
together with future multidomain intervention studies follow-
ing the protocol of the FINGER study, will provide addi-
tional understanding on the beneﬁts of multidomain lifestyle
interventions on the prevention of disability among old peo-
ple at risk of cognitive decline.
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